Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients

Authors

  • Deepali D. Pawar,

    Corresponding author
    1. Department of Periodontics, Bapuji Dental College and Hospital, Davangere, India
    • Correspondence

      Dr Deepali D. Pawar, Department of Periodontics, Bapuji Dental College and Hospital, Room No. 5, Davangere, Karnataka 577004, India.

      Tel: +91-8149-474380

      Fax: +91-8192-220572

      Email: deepali.pawar11@gmail.com

    Search for more papers by this author
  • Dhoom S. Mehta

    1. Department of Periodontics, Bapuji Dental College and Hospital, Davangere, India
    Search for more papers by this author

Abstract

Aim

The aim of the present study was to estimate the gingival crevicular fluid (GCF) levels of matrix metalloproteinases (MMP)-3 and -13 in periodontally-healthy controls and chronic periodontitis (CP) patients, and also to investigate the effect of phase 1 periodontal therapy on MMP-3 and -13 levels in CP patients.

Methods

Fifty-five systemically-healthy patients were divided into two groups: group 1 (healthy) and group 2 (CP). The recording of clinical parameters and GCF sampling was done at baseline for both groups and again at 6 weeks post-therapy for group 2. The MMP level was determined by ELISA.

Results

A significant increase in the mean MMP-3 and -13 was found between healthy and CP patients. There was a statistically-significant reduction of GCF MMP-3 and -13 concentration after periodontal therapy in the CP group. A positive correlation was found between clinical parameters and GCF MMP-3 and -13 levels.

Conclusions

A lower concentration of GCF MMP-3 and -13 was found in healthy patients, and a higher concentration was noted for CP patients, which was reduced after periodontal therapy. This indicates the important role played by these MMP in periodontal destruction. Thus, MMP-3 and -13 could be used as inflammatory biomarkers in diagnosing periodontal disease severity.

Ancillary